Why the study?
Does the transcardiac increase of NT-proBNP correlate with the severity of coronary artery stenosis in patients with stable CAD?
Population
251 consecutive patients with stable coronary artery disease undergoing angiographic examination, mean age…
Comparison
Measurement of transcardiac increase of… vs Patients without significant coronary artery…
Design
Cross-sectional, Angiograms were assessed by 2 experienced angiographers who…
Follow-up
3 months (for PCI subgroup)
Authors
Loading...
NT-proBNP transcardiac gradient may indicate stenosis severity in stable CAD; leaves open its utility for clinical decision-making pending prospective studies.
Does the transcardiac increase of NT-proBNP correlate with the severity of coronary artery stenosis in patients with stable CAD?
The transcardiac secretion of NT-proBNP, but not BNP, increases with the severity of coronary artery stenosis independently of hemodynamic overload, suggesting NT-proBNP may be a superior biomarker for assessing CAD severity.
Sakai et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: